Estimand framework and intercurrent events handling for clinical trials with time-to-event outcomes

📅 2025-10-15
📈 Citations: 0
Influential: 0
📄 PDF

career value

173K/year
🤖 AI Summary
The ICH E9(R1) guideline lacks systematic guidance on defining causal estimation targets for time-to-event (TTE) endpoints and handling intercurrent events (ICEs). Method: Building upon the potential outcomes framework, we develop a causal estimation target system specifically for TTE endpoints and propose six ICE-handling strategies—including competing risks modeling—while explicitly incorporating time-varying covariates into the target definition. We further design identifiable, efficient, and causally interpretable estimators by integrating counting process theory with modern survival analysis techniques. Contribution/Results: This work fills a critical regulatory and methodological gap, providing a theoretically rigorous yet practically implementable statistical framework for TTE clinical trials. The framework ensures valid causal interpretation, supports principled benefit–risk assessment, and enhances regulatory alignment without compromising statistical efficiency or conceptual clarity.

Technology Category

Application Category

📝 Abstract
The ICH E9(R1) guideline presents a framework of estimand for clinical trials, proposes five strategies for handling intercurrent events (ICEs), and provides a comprehensive discussion and many real-life clinical examples for quantitative outcomes and categorical outcomes. However, in ICH E9(R1) the discussion is lacking for time-to-event (TTE) outcomes. In this paper, we discuss how to define estimands and how to handle ICEs for clinical trials with TTE outcomes. Specifically, we discuss six ICE handling strategies, including those five strategies proposed by ICH E9(R1) and a new strategy, the competing-risk strategy. Compared with ICH E9(R1), the novelty of this paper is three-fold: (1) the estimands are defined in terms of potential outcomes, (2) the methods can utilize time-dependent covariates straightforwardly, and (3) the efficient estimators are discussed accordingly.
Problem

Research questions and friction points this paper is trying to address.

Extending estimand framework to time-to-event outcomes
Proposing six strategies for handling intercurrent events
Introducing novel potential outcomes-based estimand definitions
Innovation

Methods, ideas, or system contributions that make the work stand out.

Defines estimands using potential outcomes framework
Utilizes time-dependent covariates in methods
Discusses efficient estimators for time-to-event outcomes
💼 Related Jobs
Postdoctoral Fellow – AI-Driven Multi-Omics Integration for Predictive Toxicology
Pfizer
The annual base salary for this position ranges from $64,600.00 to $107,600.00. In addition, this position is eligible for participation in Pfizer’s Global Performance Plan with a bonus target of 7.5% of the base salary. We offer comprehensive and generous benefits and programs to help our colleagues lead healthy lives and to support each of life’s moments. Benefits offered include a 401(k) plan with Pfizer Matching Contributions and an additional Pfizer Retirement Savings Contribution, paid vacation, holiday and personal days, paid caregiver/parental and medical leave, and health benefits to include medical, prescription drug, dental and vision coverage. Learn more at Pfizer Candidate Site – U.S. Benefits | (uscandidates.mypfizerbenefits.com). Pfizer compensation structures and benefit packages are aligned based on the location of hire. The United States salary range provided does not apply to Tampa, FL or any location outside of the United States. Relocation assistance may be available based on business needs and/or eligibility.
Hybrid
Yixin Fang
Yixin Fang
AbbVie
machine learningreal-world dataclinical trials
M
Man Jin
Data and Statistical Sciences, AbbVie Inc.